Partnering News

University of Pittsburgh Forms Partnership with bioMérieux

Through the efforts of the University of Pittsburgh Office of Industry and Economic Partnerships, the university has formed a research and development partnership with bioMérieux, a French biotech company that is a worldwide leader in in-vitro diagnostics and testing solutions for infectious diseases. The relationship will engage the company's Analytical and Sequencing team with Pitt's Division of Clinical Microbiology and Division of Infectious Diseases.

Read full article » 

Coeptis Therapeutics Expands License Agreement with University of Pittsburgh to Include SNAP-CAR NK Cell Technology

WEXFORD, Pa., Oct. 11, 2023 /PRNewswire/ -- Coeptis now has exclusive rights to SNAP-CAR NK and SNAP-CAR T-Cell technology platforms.

Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) ("Coeptis" or "the Company"), a biopharmaceutical company developing innovative cell therapy platforms for cancer, today announced that it has expanded its exclusive license agreement with the University of Pittsburgh to include the SNAP-CAR technology platform in natural killer (NK) cells.

Read full article » 

An Alliance of Innovation Pitt, Lubrizol Corporation Look Back at Past Decade of Research Collaboration to Envision What May Lie Ahead

October 3, 2023 When the partnership between the University of Pittsburgh and The Lubrizol Corporation first formed in 2013, a $1.2 million agreement planted the seed for what would become a commitment to fostering a new future of chemistry and engineering science.

Flash forward a decade when earlier this month, Lubrizol executives including President and CEO Dr. Rebecca Liebert, visited Pitt’s Swanson School of Engineering and School of Medicine to learn about the fruits of that initial alliance, and what future opportunities may appear as the Wickliffe, Ohio-headquartered company continues to expand its industry footprint.

Read the full article >>

Pitt Researchers Join Industry-Academic Cancer Research Consortium

June 1, 2023 5:54PM EDT -- Owkin Powers a New Era in Oncology Research with MOSAIC (Multi Omni Spatial Atlas In Cancer) – MOSAIC is a landmark $50 million project to revolutionize cancer research through the use of spatial omics, a set of cutting edge technologies that offer unprecedented information on the structure of tumors. Read the full article >>

Powering Up a New Research & Education Partnership

May 9, 2023 -- Milsoft Utilities Solutions and Pitt’s Swanson School of Engineering sign research and education agreement for power distribution software. Read full article »

Inside labs at the University of Pittsburgh, Researchers are cracking the code to Save Lives Now and in the Future

March 13, 2023 / 8:24 PM / CBS PITTSBURGH (KDKA)

While the COVID-19 virus wreaked havoc, scientists here and across the country were looking for a vaccine.Three years later, Dr. Paul Duprex, director of the Pitt Center for Vaccine Research Director, admits the science community was not ready for coronavirus to be the source of such destruction. "I think that is reasonable to say, it surprised many people," he said. Read full article »

Coeptis Therapeutics Enters into Sponsored Research Agreement with the University of Pittsburgh to Advance SNAP-CAR Development Program

WEXFORD, Pa., Jan. 31, 2023 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) ("Coeptis" or "the Company"), a biopharmaceutical company developing innovative cell therapy platforms for cancer, today announced a sponsored research agreement with the University of Pittsburgh to advance pre-clinical development of SNAP-CAR T cells targeting HER2 as well as identify opportunities to expand the applicability of SNAP-CAR in oncology.  SNAP-CAR, which Coeptis licensed from the University of Pittsburgh, is a multi-antigen chimeric antigen receptor T cell (CAR T) technology that can be adapted to different cancer indications, including hematologic and solid tumors. Read full article »

Genprex Partnering with the University of Pittsburgh

Dec. 15, 2022 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced it has entered into an exclusive license agreement (the Agreement) with the University of Pittsburgh, granting Genprex a worldwide, exclusive license to certain patent applications and related technology and a worldwide, non-exclusive license to use certain related know-how, all related to modulating autoimmunity in Type 1 diabetes by using gene therapy. Read full article » 

Our Region's Business - Dr. Jason Lohmueller, Assistant Professor with Pitt's Department of Immunology

December 19, 2022 - Dr. Jason Lohmueller, Assistant Professor with Pitt's Department of Immunology is joined by Coeptis Therapeutics' CEO, Dave Mehalick, on WPXI-TV. Watch the segment to learn more about this partnership around SNAP-CAR and Cell Therapy. Watch the Interview on WPXI Channel 11 News.

Alstom and Pitt's Swanson School of Engineering Look to Solve Mobility Issues through Partnership

Dec 14, 2022 - Ethan Lott - Pittsburgh Business Times

Mark Gruber, head of the urban rail development center with Alstom, talks about Alstom and its partnership with the University of Pittsburgh's Swanson School of Engineering. Read more.

Related: Watch Alstom Head of Development Centers - Americas - Urban Platform and Pitt Engineering alumnus Mark Gruber PE BSEE ‘06 talks about Alstom and the MOU with KDKA-TV’s Jon Delano.

Peoples Gas Partners with Pitt

September 21, 2022 - PITTSBURGH--(BUSINESS WIRE)--The University of Pittsburgh and Peoples Gas, an Essential Utilities company, are teaming up to explore the use of hydrogen as a future energy source. Together, the organizations announced today they will enter a research partnership to study the potential of safely and securely transporting hydrogen through its natural gas systems. Read full article » 

ElevateBio and the University of Pittsburgh Announce Creation of Pitt BioForge BioManufacturing Center at Hazelwood Green to Accelerate Cell and Gene Therapy Innovation

August 25, 2022 – ElevateBio, LLC (ElevateBio) and the University of Pittsburgh announced they have entered into a long-term strategic partnership to accelerate the development of highly innovative cell and gene therapies. Through this agreement, ElevateBio will locate one of its next BaseCamp process development and Good Manufacturing Practice (GMP) manufacturing facilities in Pittsburgh, fully equipped with its enabling technologies, including gene editing, induced pluripotent stem cell (iPSC) and cell, vector, and protein engineering capabilities. The University of Pittsburgh has long been a research powerhouse and is consistently among the top U.S. institutions in National Institutes of Health research funding. Read full article »

Pitt-UPMC-Bayer Collaboration to fight Chronic Kidney Disease

May 13, 2022 - One in seven American adults — 37 million people — have chronic kidney disease (CKD), an incurable condition with few treatments available to slow its progression or delay organ failure. Read full article »

Cultivating Industry-Academia Partnerships

April 23, 2022 - Pitt's Office of Industry and Economic Partnerships was recently featured in the University-Industry Engagement Advisor for its efforts to implement a more targeted marketing strategy focused on high-value opportunities.

Historically, large research universities have marketed their available technologies and start-ups by solely listing them on the university portal. More recently, the universities of Virginia, Michigan and Pittsburgh have developed and are using a more targeted approach to reach prospective partners and it's working. Read full article »

Pitt and Duquesne Light Partner for a Powerful Future

January 4, 2022 - To keep pace with the rapidly evolving technology of electric power systems, the University of Pittsburgh Energy GRID Institute and Duquesne Light Co. (DLC) are partnering to create a collaborative platform to advance and implement innovative solutions in support of a more secure, resilient, and clean energy grid. Read full article »

The University of Pittsburgh and Orange Grove Bio Establish Partnership to Develop and Commercialize Novel Therapeutics

NEW YORK and PITTSBURGH, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Orange Grove Bio, a preclinical drug investment and development firm, and the University of Pittsburgh today announced the establishment of a collaboration designed to advance the development and commercialization of novel therapeutics by supporting the translation of scientific discoveries made by researchers at the University of Pittsburgh. The newly established partnership will aim to cultivate the Pittsburgh biotech landscape by increasing entrepreneurship, education, and scientific translation of promising technologies. These efforts will be focused in the areas of oncology and autoimmune and inflammatory diseases. Read full article »

Covestro LLC and University of Pittsburgh collaborate to establish groundbreaking Circular Economy Program

November 16, 2021 - A new collaboration between the University of Pittsburgh and Covestro LLC takes aim at decreasing global waste and its impact on the environment and climate.The Covestro Circular Economy Program will enable students at the University of Pittsburgh to become experts in circular economy principles, informed by Covestro’s successes in this area, and ultimately create circular, sustainable products and service solutions. Read full article » 

Astellas and University of Pittsburgh